Search
Azenta Inc
AZTAAdd to Watchlist
28.130USD
-0.670-2.33%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.30BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Azenta Inc is 7.43, ranking 292 out of 385 in the Biotechnology & Medical Research industry. The average price target is 41.00, with a high of 45.00 and a low of 31.00.
Analyst Rating
Based on
7
analysts
Buy
Current Rating
29.833
Target Price
+6.06%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Azenta Inc
AZTA
7
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Azenta Inc's expected revenue for the next quarter?
Azenta Inc's expected revenue is 149.29M.
What is Azenta Inc's price target?
Analysts forecast that Azenta Inc's price target is USD 41.00, with the highest forecast at USD 45.00 and the lowest forecast at USD 31.00.
How have Azenta IncAZTA's recent earnings per share performed?
The market expectation was USD -3.49, while Azenta IncAZTA's earnings per share (EPS) for the previous quarter was USD -0.34. EPS for the next quarter is expected at USD 0.11.
What is the analyst rating for Azenta Inc?
Based on the ratings of Azenta Inc's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.